Physician profile
Johnny E Johnson
NPI 1588692628
$1,995.77
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,082 · 2020: $309 · 2021: $184 · 2023: $66.71 · 2024: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.13 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $726.60 | 2019-2024 | |
| Abbvie INC. | $248.38 | 2019-2021 | |
| Allergan, INC. | $162.21 | 2019-2020 | |
| Ibsa Pharma INC. | $151.77 | 2019-2020 | |
| Johnson & Johnson Health Care Systems INC. | $145.18 | 2024 | Akeega |
| Vertical Pharmaceuticals, LLC | $136.71 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.12 | 2019 | |
| Therapeuticsmd, INC. | $90.00 | 2019-2020 | |
| Pfizer INC. | $88.09 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.26 | 2019 | |
| Gilead Sciences, INC. | $28.94 | 2019 | |
| Amag Pharmaceuticals, INC. | $22.00 | 2019 | |
| Astellas Pharma US INC | $21.64 | 2019 | |
| Lupin INC. | $12.81 | 2019 | |
| Dysis Medical, INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.